Ionis Finds Its Footing Ahead Of Its First Big Commercial Step
CEO Brett Monia Took The Helm At Start Of Transition
Ionis will launch its first commercial product through a co-commercialization agreement with AstraZeneca early next year, in preparation for its first wholly-owned drug launches soon to follow.
